{"nctId":"NCT00275275","briefTitle":"Pramipexole Conversion to Ropinirole Controlled Release (CR)","startDateStruct":{"date":"2006-01"},"conditions":["Parkinson Disease"],"count":61,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: Requip PR","Drug: Mirapex"]},{"label":"2","type":"EXPERIMENTAL","interventionNames":["Drug: Requip PR","Drug: Mirapex"]},{"label":"3","type":"EXPERIMENTAL","interventionNames":["Drug: Requip PR","Drug: Mirapex"]}],"interventions":[{"name":"Requip PR","otherNames":["Requip 24-hour prolonged release (PR)."]},{"name":"Mirapex","otherNames":["Pramipexole"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Diagnosis of Parkinson Disease\n* Currently taking pramipexole\n* Never have taken Requip CR\n\nExclusion Criteria:\n\n* Can not have significant adverse effects to standard Requip\n* Can not have atypical PD due to drugs, metabolic disorders, encephalitis or degenerative diseases\n* Can not have unstable medical conditions\n* Can not be taking concurrent monoamine oxidase inhibitors except for selegiline (10mg per day or less)\n* Female patients of childbearing potential must be using an effective method of contraception.\n* Can not be pregnant or lactating.\n\nThis may not be a complete list; there may be additional criteria which may apply.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Adverse Effects Experienced","description":"Number of adverse effect experienced by participants in the different conversion ratio groups.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"29","spread":null},{"groupId":"OG001","value":"43","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Dose Adjustments","description":"Outcome measures the number of times a dose needed to be adjusted to compensate for adverse effects experienced.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.6","spread":"0.7"},{"groupId":"OG001","value":"1.3","spread":"1.2"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":33},"commonTop":["PD worsening","Dizziness","Nausea","Somnolence","Anxiety"]}}}